To determine whether the components of the uPA system could be used as biomarkers for severe pulmonary involvement in SSc, we investigated the association between the serum uPA, PAI-1, and suPAR levels and the presence of lung interstitiopathy, restrictive lung disease, and reduced DLCO. The gene discussed is PLAU; the disease is Restrictive ventilatory defect.